These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1895044)

  • 41. A comparison of the efficacy and tolerability of enalapril and sustained-release diltiazem in mild to moderate essential hypertension.
    Weir MR; Haynie R; Vertes V; Pinson R; Kong BW; Jenkins P; Lavin PT
    Clin Ther; 1990; 12(6):473-81. PubMed ID: 2289216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enalapril monotherapy in essential hypertension.
    Verma NP; Madhu SV
    J Assoc Physicians India; 1992 Feb; 40(2):84-6. PubMed ID: 1629142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH; Matzek KM; Kempthorne-Rawson J
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Swiss hypertension treatment programme with verapamil and/or enalapril in diabetic patients.
    Ferrier C; Ferrari P; Weidmann P; Keller U; Beretta-Piccoli C; Riesen WF
    Drugs; 1992; 44 Suppl 1():74-84. PubMed ID: 1283588
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Antihypertensive efficacy and tolerability of diltiazem and enalapril, alone or in combination. DESG. Diltiazem Enalapril Study Group].
    Zannad F; Gosse P; Bernard-Fernier MF; de La Garoullaye A
    Presse Med; 1994 Oct; 23(29):1335-8. PubMed ID: 7984540
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amlodipine with enalapril therapy in moderate-severe essential hypertension.
    Jensen H; Garsdal P; Davies J
    J Hum Hypertens; 1990 Oct; 4(5):541-5. PubMed ID: 2149389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation and quality-of-life assessment of amlodipine and enalapril in patients with hypertension.
    Omvik P; Herland OB; Thaulow E; Eide I; Midha R; Turner RR
    J Hum Hypertens; 1995 Mar; 9 Suppl 1():S17-24. PubMed ID: 7783109
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of different fixed antihypertensive combination drugs: a double-blind, placebo-controlled parallel group study.
    de Leeuw PW; Notter T; Zilles P
    J Hypertens; 1997 Jan; 15(1):87-91. PubMed ID: 9050975
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of enalapril and hydrochlorothiazide on blood pressure, renin-angiotensin system, and atrial natriuretic factor in essential hypertension: a double blind factorial cross-over study.
    Chalmers JP; Wing LM; West MJ; Bune AJ; Elliott JM; Morris MJ; Cain MD; Graham JR; Southgate DO
    Aust N Z J Med; 1986 Aug; 16(4):475-80. PubMed ID: 3026294
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A multicentre study to compare the therapeutic efficacy of sustained-release diltiazem and enalapril in the treatment of patients with mild to moderate hypertension.
    Weir RJ; Lee PS; Clegg DS; Hemingray S; Belgrave GP; Walter E
    Br J Clin Pract; 1994; 48(6):287-92. PubMed ID: 7848788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of mild hypertension with low once-daily doses of a sustained-release capsule formulation of verapamil.
    Davis PJ; Fagan TC; Topmiller MJ; Levine JH; Ferdinand KC
    J Clin Pharmacol; 1995 Jan; 35(1):52-8. PubMed ID: 7751413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group.
    Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC
    Am J Cardiol; 1997 Feb; 79(4):431-5. PubMed ID: 9052345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
    Fermé I; Djian J; Tcherdakoff P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR; Chen CH; Ding PY; Chen YT; Ting CT; Huang JL; Chiang AH; Liu CP; Tseng CJ; Chao CT; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
    Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK
    J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide.
    Dahlöf B; Andrén L; Eggertsen R; Jern S; Svensson A; Hansson L
    J Hypertens Suppl; 1985 Dec; 3(3):S483-6. PubMed ID: 2856773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    Mancia G; Omboni S; Chazova I; Coca A; Girerd X; Haller H; Parati G; Pauletto P; Pupek-Musialik D; Svyshchenko Y;
    J Hypertens; 2016 Jan; 34(1):139-48. PubMed ID: 26630216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
    Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
    Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antihypertensive and renal effects of orally administered verapamil.
    Leonetti G; Sala C; Bianchini C; Terzoli L; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):375-82. PubMed ID: 7002568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of amlodipine with enalapril in the treatment of isolated systolic hypertension.
    Webster J; Fowler G; Jeffers TA; Lyons D; Witte K; Crichton WA; Wickham EA; Sanghera SS; Cornish R; Petrie JC
    Br J Clin Pharmacol; 1993 May; 35(5):499-505. PubMed ID: 8512762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.